Generex Biotechnology Corp. (fka GNBTQ)

[WhatDoesItAllMean]

Ten points as I see it:

(1) Generex has potentially two blockbuster technologies that could be paradigm shifts in both diabetes and cancer.

(2) Both are platform technologies that have other applications.

(3) OralLyn testing is near completion.

(4) There are no guarantees either technology will work but indications are they do.

(5) If either technology does work the company is worth 9 digits.

(6) If a company is on its way down then a reverse split signals disaster. However due to the aforementioned points, the opposite is the case here. Therefore, I am voting FOR the reverse split. If the technologies do in fact work then although there may be a momentary drop the benefits FAR outweigh the blip in price. The price will be propelled upward with testing success.

(7) The 51% buyout ensures a stronger position vis a vis partnerships as GNBT can now go it alone with ready infrastructure and can bargain harder.

(8) The purchased company is cash flow positive so money aka profits will fund future testing.

(9) GNBT is thinking not only science but monetizing the technologies.

(10) Management is thinking strategically, not just tactically.